Glycoconjugates Play a Key Role in Campylobacter jejuni Infection: Interactions between Host and Pathogen by Christopher James Day et al.
CELLULAR AND INFECTION MICROBIOLOGY
REVIEW ARTICLE
published:
doi: 10.3389/fcimb.2012.00009
Glycoconjugates play a key role in Campylobacter jejuni
infection: interactions between host and pathogen
Christopher James Day†, Evgeny Alexander Semchenko† andVictoria Korolik*
Institute for Glycomics, Grifﬁth University, Gold Coast, QLD, Australia
Edited by:
Alain Stintzi, Ottawa Institute of
Systems Biology, Canada
Reviewed by:
Marina Šanti, University of Rijeka,
Croatia
Christine M. Szymanski, University of
Alberta, Canada
*Correspondence:
Victoria Korolik , Institute for
Glycomics, Grifﬁth University, Gold
Coast, QLD 4222, Australia.
e-mail: v.korolik@grifﬁth.edu.au
†Christopher James Day and Evgeny
Alexander Semchenko have
contributed equally to this work.
Glycan based interactions between host and pathogen are critical in many bacterial and viral
diseases. Glycan interactions range from initial receptor based adherence to protecting the
infective agent from the host’s immune response through molecular mimicry. Campylobac-
ter jejuni is an ideal model for studying the role of glycans in host–pathogen interactions,
as well as the role of bacterial surface glycoconjugates in infection. Using glycan array
analysis, C. jejuni has been shown to interact with a wide range of host glycoconjugates.
Mannose and sialic acid residues appear to play a role in initial interactions between host
and pathogen following environmental exposure, whereas fucose and galactose based
interactions are likely to be required for prolonged colonization. Other studies have high-
lighted potential decoy receptor type interactions between host’s intestinal mucins and
C. jejuni, demonstrating the importance of host glycoproteins as defense against C. jejuni
infection as well as the role for glycoconjugates found in human breast milk in protection
of breast feeding infants from infection with C. jejuni. C. jejuni can produce N- and O-
linked glycoproteins, capsular polysaccharide (CPS) and/or lipooligosaccharide (LOS) which
results in C. jejuni presenting its own diverse sugar coated displays on the cell surface.
Bacterial glycans play an important and versatile role in infection and disease. Of these, the
best understood is the molecular mimicry of human gangliosides presented by C. jejuni ’s
LOS and its link to the onset of autoimmune neuropathies such as the Guillain Barrè syn-
drome (GBS). However, the role of glycoconjugates presented by C. jejuni extends beyond
expression of sialylated ganglioside structures involved in initiation of GBS. Expression of
surface glycans by C. jejuni may also relate to the ability of this organism to interact with
the glycoproteins for initial host–pathogen interactions and continued infectivity.
Keywords: glycans, LOS, glycoconjugates
INTRODUCTION
Glycosylation is a ubiquitous decoration of proteins, lipids, and
other molecules (such as organic acids) with carbohydrate struc-
tures by all living cells (Lehmann et al., 2006). For pathogenic
bacteria both the presentation of surface glycans and the recogni-
tion of host cell glycans are crucial for the survival in, colonization,
and continued infection of host tissues (Lehmann et al., 2006).
Campylobacter jejuni has been shown to present a wide array of
glycans to aid in the evasion of the host immune responses and to
protect itself fromhost defenses, including proteolytic degradation
(Karlyshev et al., 2005b). Recently C. jejuni has also been shown to
bind to a diverse range of host glycans that are potentially crucial
for the initial attachment to and continued colonization of the
host (Morrow et al., 2005; Day et al., 2009). Here we discuss recent
data on both, the factors involved in the heterogeneous expression
of lipooligosaccharide (LOS) by C. jejuni and the importance of
the interactions of C. jejuni with host glycans for colonization and
infection.
IMPORTANCE OF GLYCANS FOR INFECTION
To infect a host, bacterial pathogens must be equipped with mul-
tiple factors to assist in colonization and depending on the site of
infection, these factors vary widely. Some bacterial species must be
highly motile and sensitive to small chemical gradients to success-
fully locate their niche, while other species require no self motility
to successfully infect the host tissues they prefer. Initial con-
tact between host and pathogen occurs most frequently through
bacterial surface components that mediate adherence which are
collectively called adhesins. As the host cell surfaces display mul-
titude of glycoconjugates, it is not surprising that a large number
of bacteria express carbohydrate speciﬁc adhesins and that expres-
sion of speciﬁc lectin style adhesins is thought to be responsible for
the tissue tropism of pathogens (Sokurenko et al., 1998; Lehmann
et al., 2006; Lloyd et al., 2007).
A diverse range of glycoconjugates has now been identiﬁed
as targets of pathogenic microbes including fucosylated glycans
(e.g., Pseudomonas aeruginosa), gangliosides, and lactoceramides
(e.g.,Helicobacter pylori), sialylated glycans (e.g.,Streptococcus gor-
donii), and mannosylated structures (e.g.,Escherichia coli; Gilboa-
Garber et al., 1994; Thomas et al., 2002; Lehmann et al., 2006;
Yajima et al., 2008). One of the best deﬁned glycan dependent
interactions with host tissues is the recognition of mannosylated
glycoconjugates by the FimH protein of E. coli (Sokurenko et al.,
1994, 1998; Klemm et al., 1996; Aprikian et al., 2007; Rosen et al.,
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2008; Sepehri et al., 2009). Not only has this been deﬁned as
a key interaction required for colonization, commensalism, and
infections with E. coli; but also depending on the chain length of
the mannose recognized by FimH, it identiﬁes the favored niche
of the E. coli strain (Sokurenko et al., 1998; Pouttu et al., 1999;
Rosen et al., 2008). E. coli strains that interact through FimH with
short repeat mannosylated glycoconjugates tend to be uropath-
ogenic, while those that recognize longer mannose repeats tend
to be found as either commensals or pathogens in intestinal and
colonic tissues (Sokurenko et al., 1998; Rosen et al., 2008). Many
other bacteria, including Streptococcus spp. andNeisseria spp.,have
been shown to require interactions with host glycans for successful
infection (Lehmann et al., 2006; Lloyd et al., 2007; Sharon, 2008),
however, the factors involved in these interactions have not always
been elucidated (Scharfman et al., 1999; Day et al., 2009).
DEFINED GLYCAN BINDING IN THE
EPSILONPROTEOBACTERIA: HELICOBACTER PYLORI
Carbohydrate based interactions have not been fully solved for C.
jejuni, but the related species Helicobacter pylori has been exten-
sively studied and the lectins involved in carbohydrate dependent
interactions have been well characterized (Utt and Wadstrom,
1997; Ilver et al., 1998; Mahdavi et al., 2002; Cooksley et al., 2003;
Hynes et al., 2003; Bennett and Roberts, 2005;Walz et al., 2005). H.
pylori exhibits broad complexity in carbohydrate-binding speci-
ﬁcity, owing to the expression of six different lectins/adhesins with
speciﬁcities for sialylated oligosaccharides, Lewis B antigen, lacto-
sylceramide and ganglioseries glycolipids, and heparan sulfate (Utt
and Wadstrom, 1997; Ilver et al., 1998; Mahdavi et al., 2002; Cook-
sley et al., 2003; Hynes et al., 2003; Bennett and Roberts, 2005;
Walz et al., 2005). Of these six lectins, only four (SabA, BabA,
HapA, and Hbp) are actually involved in adherence of the bacteria
to host tissues, while the other two (HP-NAP and HP0721) appear
to be involved in the “mopping up” of free sialic acid in chroni-
cally infected tissue. It has been proposed for H. pylori that initial
interactions with host tissues may be achieved through binding
to non-sialylated glycoconjugates present in the normal gastric
epithelium (e.g., Lewis B antigen and glycosphingolipids). While,
the sialic acid binding capacity of H. pylori is likely to enable per-
sistence of H. pylori infection by mediating adhesion through the
sialic acid binding lectin, SabA, to the already diseased epithelium
of the stomach of chronically infected hosts (Figure 1; Mahdavi
et al., 2002).
CAMPYLOBACTER JEJUNI GLYCAN DEPENDENT
INTERACTIONS WITH HOST TISSUES
Like H. pylori, C. jejuni has been reported to have a broad binding
speciﬁcity for glycans and is known to interact with mucins and
other glycoproteins (Hugdahl et al., 1988; McAuley et al., 2007; Tu
et al., 2008; Stahl et al., 2011). Through glycan array based analy-
sis, we have identiﬁed the binding of C. jejuni strain NCTC11168
to galactose, fucose, sialic acid, mannose, glucosamine, and gly-
cosaminoglycans, however, the interactions with glycans were
dependent on the conditions that C. jejuni were grown or main-
tained (Day et al., 2009). C. jejuni NCTC11168 was found to bind
glycans terminating in galactose regardless of linkage (both α-
FIGURE 1 | Campylobacter jejuni and H. pylori host glycoconjugate
recognition. H. pylori recognizes lactoceramides and fucosylated
structures for the initial contact swapping to sialylated structures during
chronic infection. C. jejuni does the opposite recognizing sialic acid and
mannose for initial contact and swapping to fucose and galactose after
establishing the infection. The proteins involved in H. pylori
glycoconjugate recognition are known but in C. jejuni they have yet to be
elucidated.
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and β-linked) and fucosylated glycans when grown under condi-
tions mimicking mammalian and avian hosts. Less binding was
observed to fucosylated and terminal galactose structures when
maintained in conditions mimicking environmental stress (Day
et al., 2009). Conversely, direct interactions between C. jejuni
NCTC11168 and sialic acid or mannose containing glycoconju-
gates was observed in glycan array experiments but only after the
bacteria were put under environmental stress (Day et al., 2009).
The glycan based interactions observed for C. jejuni NCTC11168
under the different conditions has been replicated in numerous
other strains (unpublished data). Of the 11 other C. jejuni strains
[human isolates: 11168; 351; 375; 520; 81116 and 81-176 and
chicken isolates: 008; 019; 108; 331; 434 and 506] tested so far at all
three conditions (environmental, 37, and 42˚C)], nine have been
found to bind to almost identical structures under the same con-
ditions as C. jejuni NCTC11168. The two exceptions are atypical
C. jejuni strains, still under investigation. These glycan dependent
interactions and the way in which C. jejuni is able to modulate
its binding of glycoconjugates under different conditions, allows
us to hypothesize that mannose and sialic acid based adherence
is required for initial contact with host tissues after exposure
to the external environment, with long term infection resulting
from interactions with fucose and terminal galactose containing
glycoconjugates (Figure 1; Day et al., 2009).
It is interesting to note the differences in the way that C. jejuni
and H. pylori interact with glycoconjugates may explain why bac-
teria that are closely related infect different niches within the same
host (Figure 1). For H. pylori, normal stomach mucosal tissue is
mostly glycosylatedwith fucosylated structures such asLewisB and
is rich in lactoceramides,while being poor in sialylated glycoconju-
gates. The inﬂamed stomach, however, produces a highly sialylated
mucosal layer therefore requiring H. pylori to recognize sialic acid
in order to maintain chronic infections (Mahdavi et al., 2002).
In contrast, for C. jejuni, the initial interactions in the intestinal
tissues are with proteins such as MUC1, a highly sialylated and
mannosylated structure. MUC1, a cell surface bound mucin, is a
decoy receptor and is released from by the intestinal epithelium
into the intestinal lumen when recognized by pathogens such as
C. jejuni (McAuley et al., 2007; Linden et al., 2008). Due to this
the continued binding of sialic acid by C. jejuni, once it has begun
to adjust to the host environment, would be detrimental to long
term infection. The crypts of the intestinal epithelium, C. jejuni’s
favored niche, are rich in a gel forming mucin MUC2, a protein
with signiﬁcantly less sialylation thanMUC1. It is here in the crypts
and at the epithelial surface, away from the lumen of the intesti-
nal tract, that C. jejuni would gain advantage from recognizing
fucosylated and terminal galactose structures as these become the
predominant structures presented by the host (Day et al., 2009).
We have also shown that adherence to cultured Caco-2 colonic
epithelial cells could be signiﬁcantly reduced when C. jejuni bind-
ing was competed against commercially available lectins, partic-
ularly those lectins with speciﬁcity for fucose and galactose (Day
et al., 2009). Almost complete inhibition of adherence to Caco-2
cells was observed when cells were pre-incubated with the galac-
tose recognizing lectin ECA (90% inhibition of 11168-O grown
at 42˚C) or the fucose binding lectin UEA-1 (95–100% inhibi-
tion of 11168-O; Day et al., 2009). Previous studies had already
identiﬁed fucosylated glycans as crucial for interactions between
C. jejuni and host tissues (Morrow et al., 2005). These studies
identiﬁed that fucosylated glycoproteins, present in human breast
milk, could inhibit C. jejuni colonization, with Lewis B, and 2-
fucosylactose being identiﬁed as the key glycans recognized by C.
jejuni (Morrow et al., 2005). These data together with our ﬁnd-
ings highlight the crucial nature of glycan based interactions for
C. jejuni infection and colonization. It is therefore crucial that the
factors involved in the recognition of host glycans be elucidated.
Intriguingly, C. jejuni does not contain any orthologs or
homologs of the H. pylori SabA, BabA, Hbp HapA, or HP0721
lectins but does contain a protein with 65% identity to the sialic
acid binding lectin HP-NAP (Parkhill et al., 2000; Gundogdu et al.,
2007). Whether this HP-NAP homolog can act as an adhesin for
C. jejuni is yet to be determined. To date, bioinformatic analyses
have failed to identify deﬁnite glycan recognizing proteins and the
mechanisms for the recognition of such a diverse range of glycans
by C. jejuni remains a mystery. Mechanisms, other than protein
based adherence, however, may be involved in this diverse gly-
can recognition. One such mechanism may rely on the C. jejuni’s
own surface exposed glycosylation such as LOS and capsular poly-
saccharides (CPS) which have both been linked to adherence of
C. jejuni to host cells in culture, indicating a potential role for the
bacterially produced glycans in the recognition of host tissues (Fry
et al., 2000).
CAMPYLOBACTER JEJUNI SURFACE GLYCOSYLATION
Campylobacter jejuni was the ﬁrst bacteria to be identiﬁed with
the mechanism for N-linked protein glycosylation and displays a
range of glycosylated structures including N- and O-linked gly-
coproteins, LOS, and CPS (Karlyshev et al., 2005b). N-linked
glycans can either be surface expressed structures or produced
as a free oligosaccharide (Nothaft and Szymanski, 2010; Nothaft
et al., 2010). Interestingly, though the ﬂippase involved in the
attachment of the N-linked glycan to the surface is non-speciﬁc
for the structure it translocates, C. jejuni produces an N-linked
glycan structure that is highly conserved between strains (Young
et al., 2002; Linton et al., 2005; Kelly et al., 2006). O-linked gly-
cosylation in C. jejuni is exclusively found on the ﬂagella and is
critical for correct ﬂagella assembly, motility, and ﬂagella depen-
dent adherence (Thibault et al., 2001; Szymanski et al., 2003; Logan
et al., 2009). While there is some diversity in the expression of
the O-linked glycans produced by different strains, the greatest
diversity in glycosylation structures is observed for both CPS and
LOS (Moran, 1997; Moran and Penner, 1999; Karlyshev et al.,
2005a,b). CPS and LOS are also one of the most immunogenic
of the surface glycosylations presented by C. jejuni explaining
much of the strain speciﬁc immunity commonly seen with C.
jejuni infections (Karlyshev et al., 2005b; Perera et al., 2007; Mon-
teiro et al., 2009). The glycan structures of the CPS are variable
between strains with the heat stable antigen typing, which types
the combination of CPS and LOS present, being one of the ways
in which C. jejuni strains can be differentiated from one another
(Moran and Penner, 1999). However, while structure of CPS is
differential between strains and can be heterogenous in the same
strain, the structure of the outer core sugars of the LOS is almost
always heterogeneous within a population of C. jejuni of the same
strain (Linton et al., 2000a; Guerry et al., 2002; Semchenko et al.,
2010).
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LIPOOLIGOSACCHARIDE BIOSYNTHESIS CLUSTERS: LINK TO
GUILLAIN–BARRÉ SYNDROME
Lipooligosaccharide are glycolipids expressed by Gram negative
bacteria as part of their outer membrane. LOS is comprised of a
lipid A molecule attached to a polysaccharide chain with a con-
served inner core and a variable outer core. The outer core may be
present as a single copy (LOS) as seen by the pathogen Neisseria
meningitides or may repeat multiple times to produce lipopolysac-
charide (LPS) as seen in a range of bacteria including E. coli (Zhu
et al., 2002; Wang and Quinn, 2010). The LOS of C. jejuni has
been widely studied and has been hypothesized to play important
roles in cellular survival, host evasion, and adherence to host tis-
sues (Karlyshev et al., 2005b). Strain to strain variation observed
for LOS structures presented by C. jejuni has been linked to the
diversity of the genes present within the LOS biosynthesis clus-
ters (Gilbert et al., 2002). More then 20 different LOS biosynthesis
clusters have been identiﬁed in C. jejuni strains, including the ﬁve
capable of sialylation and ganglioside mimicry (A, B, C, M, and R;
Gilbert et al., 2008). One biosynthesis cluster type, type E (C. jejuni
81116), also produces a larger LPS molecule rather than an LOS
(Gilbert et al., 2008). The type E biosynthesis cluster is divergent
from those seen in other C. jejuni precursor clusters contributing
to the generation of a differential core oligosaccharide (Gilbert
et al., 2008).
To date, the ﬁve clusters with mechanisms for ganglioside mol-
ecular mimicry (A, B, C, M, and R), have been the major focus
of research into the C. jejuni LOS (Karlyshev et al., 2005b; Yuki,
2007; Gilbert et al., 2008). The most commonly used model strains
for analyzing C. jejuni NCTC11168 and 81–176 both have clus-
ters capable of ganglioside molecular mimicry, falling into cluster
types C and B, respectively. There appears to be a bias in research
toward sialylated LOS structures of C. jejuni. This is mostly due to
the focus on the strains producing LOS with ganglioside mimicry
due to their clinical signiﬁcance in the induction of Guillain–
Barré syndrome (GBS; Yuki, 1997). For example, recent studies
have demonstrated that C. jejuni with sialylated LOS binds a
sialoadhesin, which in turn leads to a cascade of events that
result in production of cross-reactive antibodies (Louwen et al.,
2008; Mortensen et al., 2009; Heikema et al., 2010; Kuijf et al.,
2010).
Campylobacter jejuni infection is usually self-limiting, but in
rare cases the infection precludes a debilitating, polyneuropathic
disorders GBS, or the oculomotor variant Fisher syndrome (FS;
Godschalk et al., 2007). C. jejuni is the most common antecedent
infection in these neuropathies and expression of LOS mimick-
ing host gangliosides is considered necessary for the neuropathy
development since such mimicry can induce the production of
self-reactive antibodies (Godschalk et al., 2007). Gangliosides are
glycosphingolipids occurring in high concentration in the periph-
eral nervous system, particularly in the nerve axon but are also
present on the epithelial cells of the entire gut, stomach through
to the colon (Nachamkin et al., 1998; Ang et al., 2004). The
production of self-reactive antibodies against these glycolipids
plays a central role in GBS and FS development (Yuki, 1997). C.
jejuni has been shown to produce ganglioside mimicries, includ-
ing those implicated in GBS (GM1, GM1b, GD1a, GalNAc–GD1a)
and FS (GQ1b, GT1a; Yuki, 1997; Ang et al., 2004). Supporting
a pathogenic role of C. jejuni in GBS, C. jejuni LOS-induced
anti-GM1 ganglioside antibodies react at the nodes of Ranvier,
where the axon is exposed in the nerve ﬁber (Moran et al., 2005),
resembling the pathology observed in GBS patients, and inoc-
ulation of C. jejuni GM1-mimicking LOS has been reported to
induce GBS-like symptoms in a rabbit model (Yuki et al., 2004).
Althoughmimicry of gangliosides byC. jejuni LOShas been exten-
sively studied structurally over the last two decades, it is important
to note that these characterization studies were performed on
strains grown almost exclusively at 37˚C. The research focus on
the growth temperature of 37˚C is completely at odds with the
lifestyle C. jejuni which colonizes a variety of niches whose tem-
peratures range from 25 to 42˚C (Blaser, 1997), and with previous
studies that have highlighted the role the growth temperature plays
in gene regulation, expression, enzymatic function, protein fold-
ing, and general bacterial metabolism (Stintzi, 2003; Semchenko
et al., 2010). All this taken together indicates that there is a need
to investigate LOS genetic and structural diversity at temperatures
which represent different hosts.
LOS STRUCTURE AND HETEROGENEITY: HOW C. JEJUNI ’S
ENVIRONMENT CAN EFFECT STRUCTURE
Campylobacter jejuni exists in wide range of temperatures and
atmospheric conditions, from normal atmospheric temperatures,
and oxygen levels, when in the environment, to 42˚C and virtu-
ally anaerobic in parts of the avian gut. While C. jejuni is thought
not to replicate when in the environment, it is capable of growth
at temperatures ranging from 30 to 47˚C and therefore is capa-
ble of growth at the body temperatures of mammalian and avian
hosts, 37 and 42˚C, respectively (Blaser, 1997). It is not surprising
that gene expression changes have been noted under these varying
conditions including the regulation of genes found in LOS biosyn-
thesis clusters (Stintzi, 2003). Recently, however, we have shown
that gene expression may not be the only change that affects the
overall LOS structure under varying conditions (Semchenko et al.,
2010).
Different temperature environments may trigger events to
accommodate the colonization, commensalism, pathogenesis, or
dormancy of this bacterium. The lack of knowledge of the struc-
ture of C. jejuni LOS at 42˚C compared to 37˚C prompted us to
examine the effect of incubation temperature on the phenotypic
variation of LOS, including the mimicry of gangliosides, in C.
jejuni strain NCTC11168. Variation in LOS structure was assessed
by electrophoretic analysis and immunoblotting and conﬁrmed
by nuclear magnetic resonance (NMR) spectroscopy. Carbohy-
drate epitopes produced were assessed for ganglioside mimicry
using various anti-ganglioside ligands (i.e., antibodies, lectins, and
cholera toxin) as probes. In addition, LOS structural variation at
these two incubation temperatures was examined in minimally
subcultured C. jejuni isolates from humans and chickens. Impor-
tantly, notable differences were observed in the relative production
by C. jejuni 11168 of varying size and ganglioside mimicries at 37
and 42˚C. At 37˚C, the LOS of C. jejuni strain 11168 was observed
to be relatively homogenous, with 90% of the total LOS produced
with structure mimicking GM1 (Semchenko et al., 2010). This
changed dramatically at 42˚C, with diversity in the LOS increas-
ing, including an increased expression of asialo-GM1) resulting in
Frontiers in Cellular and Infection Microbiology www.frontiersin.org February 2012 | Volume 2 | Article 9 | 4
Day et al. C. jejuni host and pathogen glycoconjugate interactions
just over 50%of the LOS structure present at 42˚C consisting of the
GM1-like structure seen to be dominant at 37˚C (Semchenko et al.,
2010). Thediversity in the structures seen at different temperatures
may be the result of changes in gene expression, enzymatic func-
tionality, and metabolic changes, all potentially contributing. In
addition, the C. jejuni LOS biosynthesis clusters are also known to
contain several phase variable geneswhich are subject to change.C.
jejuni strains have also been observed to functionally alter some of
their glycosyltransferases through non-phase variable alterations,
such as point mutations, on/off status, and substrate–acceptor
speciﬁcity (Linton et al., 2000a; Guerry et al., 2002; Semchenko
et al., 2010).
The LOS structures of two strains of C. jejuni, NCTC11168
and 81-176, have been extensively studied to identify the different
forms of gangliosides they can mimic and what genes/conditions
alter the host cell mimicry they can present (Linton et al., 2000a;
Guerry et al., 2002; Semchenko et al., 2010). C. jejuni NCTC11168
has class C biosynthesis cluster that typically produces LOS that
mimics monosialylated gangliosides such as GM1–2 as a result
of differential expression of galactosyltransferase – wlaN (Linton
et al., 2000a; St. Michael et al., 2002; Semchenko et al., 2010, 2011).
However, recently we have demonstrated that cluster C strains are
also capable of regulating LOS sialylation via inactivation of the
sialytransferase – cst with a transient mutation in the gene read-
ing frame (Semchenko et al., 2010, 2011). Thus cluster C strains
are capable of producing LOS structures with GM1, GM2, asialo-
GM1,and asialo-GM2 likemimicries, and depending onwhat type
of cst gene (cstII or cstIII ) they encode, they may also mono- or
di-sialylate the LOS, bringing the total of potential structures to
six from a single cluster type.
Campylobacter jejuni 81-176 has a class B biosynthesis clus-
ter that, depending on the sialytransferase expressed, encodes the
machinery to produce ganglioside mimic ranging from mono-
sialylated GM2–3 to GD structures with GM2 and GM3 being
the most commonly observed in the wild-type organism (Guerry
et al., 2002). The genes most responsible for this mimicry are the
genes coding for biosynthesis of sialic acid from N -acetylmannose
to CMP-Neu5Ac (NeuA, NeuB, NeuC) and a sialic acid trans-
ferase (CstII or CstIII; Linton et al., 2000b; Gilbert et al., 2002,
2008). Interestingly, the class C LOS biosynthesis cluster of C.
jejuni has a gene that encodes both NeuA (CMP-Neu5Ac syn-
thase) and CgtA (GalNAc transferase) in a single enzyme (Gilbert
et al., 2008). We hypothesize that the presence of this enzyme is
the reason for some of the heterogeneity observed between dif-
ferent growth conditions. Only half the LOS of C. jejuni 11168
is sialylated when grown under conditions mimicking the com-
mensal avian host but nearly 90% being sialylated at conditions
mimicking mammalian hosts (Semchenko et al., 2010, 2011). This
change in sialylation is not necessarily related to a change in the
on/off expression status of cst, but, we believe, can be due to the
differences in optimal or suboptimal enzymatic function under
different environmental stresses. This mechanism allows produc-
tion of LOS that mimics various gangliosides in a host dependant
manner, without needing to phase vary its sialic acid biosynthesis
genes (Semchenko et al., 2010, under revision). This allows the
entire population to produce different range of molecules, rather
then only a few cells that underwent a phase change, thus avoiding
a population bottleneck and increasing the ﬁtness of the infecting
population.
In other pathogens variability of surface antigens such as LOS
and protein glycosylation enable the pathogen to better evade the
immune system (Jarvis andVedros, 1987; Platt et al., 1994; Khatua
et al., 2010). This works by the host selecting or enriching for the
bacteria that present surface antigens that have not yet triggered
an immune response (Figure 2A). However, the way that LOS is
synthesized inC. jejuni,may result in heterogenous surface expres-
sion of LOS structures on a single bacteria. Single colonies of C.
jejuni NCTC11168, when screened with anti-GM1 antibodies or
cholera toxin, show uniform reactivity with the lectin/antibody,
suggesting uniform expression of the surface GM1 epitope. How-
ever, when the LOS preparations from these colonies are separated
electrophoretically, and then screened with anti-GM1 antibodies
or cholera toxin, there is heterogeneity in each sample with both
GM1 and asialo-GM1 present (Semchenko et al., 2010, 2011). We
therefore propose that C. jejuni are likely to be heterogenous for
LOS presentation on a single bacteria limiting host based selection
of successful C. jejuni clones and potentially this heterogenic LOS
FIGURE 2 | Interactions between bacterial antigens and host immune
system. (A)This is the normal process for the interactions between host
immune systems and pathogenic bacteria. (1) A portion of the bacterial
colony produces different antigens on their surfaces. (2)The immune
system targets the surface structures that are presented in a part of the
population resulting in other antigens being selected to remain. In this
example antibodies are produced to non-sialylated LOS structures. (3)The
antigens not targeted by the immune system are allowed to expand causing
the infection. (B)This is the model we think is happening for C. jejuni LOS.
(1) Each bacterium produces all potential surface antigens in different
concentrations. (2)The immune system targets the surface structures that
are presented in the population resulting antibody production against a
portion of the surface antigens. In this example antibodies are produced to
non-sialylated LOS structures. (3)The antigens not targeted by antibodies
are still present on the targeted bacteria resulting in the increased
likelihood of producing antibodies to those other LOS antigens. If the host
has a defect in the mechanisms of ensuring antibodies are not produced
against self then C. jejuni producing multiple antigens per bacteria offers a
greater risk for the production of anti-self antibodies.
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may actually contribute to the production of anti-self antibodies
seen in GBS/FS (Figure 2B).
CONCLUSION
Glycosylation of both the host surface and the bacterial sur-
face is crucial for the host–pathogen interactions observed
for C. jejuni. A better understanding of the factors involved
in glycan expression and recognition by both the bacteria
and the host may offer new insights into the mechanisms
involved in C. jejuni commensal colonization, pathogenic infec-
tion, and the induction of polyneuropathic disorders GBS
and FS.
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